aspirin and navitoclax

aspirin has been researched along with navitoclax in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fang, H; Feng, L; Li, G; Ma, X; Yan, B; Ye, X; Zhang, S; Zhao, Y	1

Other Studies

1 other study(ies) available for aspirin and navitoclax

Article	Year
Aspirin overcomes Navitoclax-resistance in hepatocellular carcinoma cells through suppression of Mcl-1. Biochemical and biophysical research communications, 2013, May-17, Volume: 434, Issue:4 Topics: Aniline Compounds; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Aspirin; Blotting, Western; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Cysteine Proteinase Inhibitors; Cytochromes c; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Oligopeptides; Proto-Oncogene Proteins c-bcl-2; RNA Interference; Sulfonamides	2013

Article

Year

Aspirin overcomes Navitoclax-resistance in hepatocellular carcinoma cells through suppression of Mcl-1.

Biochemical and biophysical research communications, 2013, May-17, Volume: 434, Issue:4

Topics: Aniline Compounds; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Aspirin; Blotting, Western; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Cysteine Proteinase Inhibitors; Cytochromes c; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Oligopeptides; Proto-Oncogene Proteins c-bcl-2; RNA Interference; Sulfonamides

2013